Use of a blood-based amyloid test for screening in INVOKE-2: a phase 2 randomized, double-blind, placebo-controlled study evaluating AL002 in early Alzheimer’s disease

AL002 - Alector, AbbVie

Brady Burgess; Tiffany Chow; Ruchi Gupta; Tuan Nguyen; Gary Romano; Adam Simmons, MD

Jun 20, 2024